Evidence map›Paper›PMID 34534337›Full record

ArticlePain medicine (Malden, Mass.)2022

Fluoroscopy-Guided High-Intensity Focused Ultrasound Neurotomy of the Lumbar Zygapophyseal Joints: A Clinical Pilot Study.

Jordi Perez, Michael Gofeld, Suzanne Leblang, Arik Hananel, Ron Aginsky, Johnny Chen, Jean-Francois Aubry, Yoram Shir

Registry-linked trialOpen access · hybridAbstract read
In one paragraph

Article in Pain medicine (Malden, Mass.), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06053255 (Safety and Efficacy of the Neurolyser XR for the Treatment of Low Back Pain Related to Sacroiliitis), which is not on this map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06053255 narecruitingnot on this mapstarted 2024, after this paper: background citation

Safety and Efficacy of the Neurolyser XR for the Treatment of Low Back Pain Related to Sacroiliitis

TypeinterventionalSponsorFUSMobile Inc.Ran2024 to 2026Enrolled10ConditionsSacroiliitisArmsHigh-intensity focused ultrasound for Sacroiliitis using the Neurolyser XR
3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 19 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Overview of Therapeutic Ultrasound Applications and Safety Considerations: 2024 Update.Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine · 2025
    Review
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 3 countries.

Jordi PerezMcGill University, Montreal, Quebec, Canada.
Michael GofeldSilver Centre for Pain Care, Toronto, Ontario, Canada.
Suzanne LeblangFocused Ultrasound Foundation, Charlottesville, Virginia, USA.
Arik HananelFUSMobile, Inc., Alpharetta, Georgia, USA.
Ron AginskyFUSMobile, Inc., Alpharetta, Georgia, USA.
Johnny ChenGeorgia Institute of Technology, Atlanta, Georgia, USA.
Jean-Francois AubryPhysics for Medicine Paris, Inserm, ESPCI Paris, CNRS, PSL Research University, Paris, France.
Yoram ShirMcGill University, Montreal, Quebec, Canada.
Clearside Biomedical (United States) · USMcGill University · CAFocused Ultrasound Foundation · USGeorgia Institute of Technology · USUniversité Paris Sciences et Lettres · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo investigate the safety and feasibility of a fluoroscopy-guided, high-intensity focused ultrasound system for zygapophyseal joint denervation as a treatment for chronic low back pain.

methodsThe clinical pilot study was performed on 10 participants diagnosed with lumbar zygapophyseal joint syndrome. Each participant had a documented positive response to a diagnostic block or a previous, clinically beneficial radiofrequency ablation. For a descriptive study, the primary outcome was the safety question. All device- or procedure-related adverse events were collected. Secondary outcome variables included the average numeric rating scale for pain, the Roland-Morris Disability Questionnaire, the Brief Pain Inventory, the Patient Global Impression of Change, the morphine equivalent dose, and the finding of the neurological examination.

resultsAll participants tolerated the procedure well with no significant device- or procedure-related adverse events; there was one episode of transient pain during the procedure. The average numeric rating scale score for pain decreased from 6.2 at baseline to 2.1 (n = 10) after 1 month, 4.9 (n = 9) after 3 months, 3.0 (n = 8) after 6 months, and 3.0 (n = 6) after 12 months. The ratio of participants who were considered a treatment success was 90% at 1 month, 50% at 3 months, 60% at 6 months, and 40% at 12 months.

conclusionsThe first clinical pilot study using a noninvasive, fluoroscopy-guided, high-intensity focused ultrasound lumbar zygapophyseal neurotomy resulted in no significant device- or procedure-related adverse events and achieved clinical success comparable with that of routine radiofrequency ablation.

Indexed as

Low Back PainZygapophyseal JointDenervationFluoroscopyHumansLumbar VertebraePilot ProjectsTreatment OutcomeAblationHigh-Intensity Focused UltrasoundNeurotomyZygapophyseal Pain

Identifiers

PMID34534337
PMCPMC8723143
OpenAlexW3200541512

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.